{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:28:20Z","timestamp":1790674100311,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genomic alterations occurring during melanoma progression and the resulting genomic heterogeneity between metastatic deposits remain incompletely understood. Analyzing 86 metastatic melanoma deposits from 53 patients with whole-exome sequencing (WES), we show a low branch to trunk mutation ratio and little intermetastatic heterogeneity, with driver mutations almost completely shared between lesions. Branch mutations consistent with UV damage indicate that metastases may arise from different subclones in the primary tumor. Selective gain of mutated <jats:italic>BRAF<\/jats:italic> alleles occurs as an early event, contrasting whole-genome duplication (WGD) occurring as a late truncal event in about 40% of cases. One patient revealed elevated mutational diversity, probably related to previous chemotherapy and DNA repair defects. In another patient having received radiotherapy toward a lymph node metastasis, we detected a radiotherapy-related mutational signature in two subsequent distant relapses, consistent with secondary metastatic seeding. Our findings add to the understanding of genomic evolution in metastatic melanomas.<\/jats:p>","DOI":"10.1038\/s41467-018-05063-1","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T09:31:30Z","timestamp":1530696690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Patterns of genomic evolution in advanced melanoma"],"prefix":"10.1038","volume":"9","author":[{"given":"E.","family":"Birkeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Poduval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8468-2050","authenticated-orcid":false,"given":"S.","family":"Nakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vodak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Meza-Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-1077","authenticated-orcid":false,"given":"E.","family":"Hovig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-3223","authenticated-orcid":false,"given":"O.","family":"Myklebost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Knappskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-6303","authenticated-orcid":false,"given":"P. E.","family":"L\u00f8nning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,10]]},"reference":[{"key":"5063_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","volume":"136","author":"DC Whiteman","year":"2016","unstructured":"Whiteman, D. C., Green, A. C. & Olsen, C. M. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J. Invest. Dermatol. 136, 1161\u20131171 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"5063_CR2","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2006.06.1325","volume":"24","author":"DC Whiteman","year":"2006","unstructured":"Whiteman, D. C. et al. Anatomic site, sun exposure, and risk of cutaneous melanoma. J. Clin. Oncol. 24, 3172\u20133177 (2006).","journal-title":"J. Clin. Oncol."},{"key":"5063_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251\u2013263 (2012).","journal-title":"Cell"},{"key":"5063_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature08658","volume":"463","author":"ED Pleasance","year":"2010","unstructured":"Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191\u2013196 (2010).","journal-title":"Nature"},{"key":"5063_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward, N. K. et al. Whole-genome landscapes of major melanoma subtypes. Nature 545, 175\u2013180 (2017).","journal-title":"Nature"},{"key":"5063_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","volume":"147","author":"F Meier","year":"2002","unstructured":"Meier, F. et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br. J. Dermatol. 147, 62\u201370 (2002).","journal-title":"Br. J. Dermatol."},{"key":"5063_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton, D. L. et al. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med 355, 1307\u20131317 (2006).","journal-title":"N. Engl. J. Med"},{"key":"5063_CR8","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","volume":"373","author":"AH Shain","year":"2015","unstructured":"Shain, A. H. et al. The genetic evolution of melanoma from precursor lesions. N. Engl. J. Med 373, 1926\u20131936 (2015).","journal-title":"N. Engl. J. Med"},{"key":"5063_CR9","doi-asserted-by":"publisher","first-page":"10995","DOI":"10.1073\/pnas.1508074112","volume":"112","author":"JZ Sanborn","year":"2015","unstructured":"Sanborn, J. Z. et al. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination. Proc. Natl Acad. Sci. USA 112, 10995\u201311000 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5063_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","volume":"4","author":"H Shi","year":"2014","unstructured":"Shi, H. et al. Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov. 4, 80\u201393 (2014).","journal-title":"Cancer Discov."},{"key":"5063_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","volume":"4","author":"EM Van Allen","year":"2014","unstructured":"Van Allen, E. M. et al. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov. 4, 94\u2013109 (2014).","journal-title":"Cancer Discov."},{"key":"5063_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1158\/2159-8290.CD-13-0631","volume":"4","author":"N Wagle","year":"2014","unstructured":"Wagle, N. et al. MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF\/MEK inhibition. Cancer Discov. 4, 61\u201368 (2014).","journal-title":"Cancer Discov."},{"key":"5063_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S1470-2045(03)01280-4","volume":"4","author":"TK Eigentler","year":"2003","unstructured":"Eigentler, T. K., Caroli, U. M., Radny, P. & Garbe, C. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol. 4, 748\u2013759 (2003).","journal-title":"Lancet Oncol."},{"key":"5063_CR14","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert, C. et al. Pembrolizumab versus Ipilimumab in advanced melanoma. N. Engl. J. Med 372, 2521\u20132532 (2015).","journal-title":"N. Engl. J. Med"},{"key":"5063_CR15","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med 364, 2507\u20132516 (2011).","journal-title":"N. Engl. J. Med"},{"key":"5063_CR16","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.ejca.2010.04.023","volume":"46","author":"C Busch","year":"2010","unstructured":"Busch, C., Geisler, J., Lillehaug, J. R. & Lonning, P. E. MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC. Eur. J. Cancer 46, 2127\u20132133 (2010).","journal-title":"Eur. J. Cancer"},{"key":"5063_CR17","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1158\/1078-0432.CCR-09-2509","volume":"16","author":"G Jonsson","year":"2010","unstructured":"Jonsson, G. et al. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin. Cancer Res. 16, 3356\u20133367 (2010).","journal-title":"Clin. Cancer Res."},{"key":"5063_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1101\/gr.125591.111","volume":"22","author":"S Turajlic","year":"2012","unstructured":"Turajlic, S. et al. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res. 22, 196\u2013207 (2012).","journal-title":"Genome Res."},{"key":"5063_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/labinvest.2016.143","volume":"97","author":"RV Rawson","year":"2017","unstructured":"Rawson, R. V. et al. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas. Lab. Invest. 97, 130\u2013145 (2017).","journal-title":"Lab. Invest."},{"key":"5063_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/pcmr.12153","volume":"26","author":"K Dutton-Regester","year":"2013","unstructured":"Dutton-Regester, K. et al. Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma. Pigment Cell Melanoma Res. 26, 852\u2013860 (2013).","journal-title":"Pigment Cell Melanoma Res."},{"key":"5063_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495 (2014).","journal-title":"Nature"},{"key":"5063_CR22","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas, N.","year":"2015","unstructured":"Cancer Genome Atlas, N. Genomic classification of cutaneous melanoma. Cell 161, 1681\u20131696 (2015).","journal-title":"Cell"},{"key":"5063_CR23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/ng.3361","volume":"47","author":"M Krauthammer","year":"2015","unstructured":"Krauthammer, M. et al. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas. Nat. Genet 47, 996\u20131002 (2015).","journal-title":"Nat. Genet"},{"key":"5063_CR24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng.2760","volume":"45","author":"TI Zack","year":"2013","unstructured":"Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet 45, 1134\u20131140 (2013).","journal-title":"Nat. Genet"},{"key":"5063_CR25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nature04217","volume":"437","author":"T Fujiwara","year":"2005","unstructured":"Fujiwara, T. et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437, 1043\u20131047 (2005).","journal-title":"Nature"},{"key":"5063_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).","journal-title":"Genome Biol."},{"key":"5063_CR27","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1073\/pnas.92.6.2350","volume":"92","author":"EA Drobetsky","year":"1995","unstructured":"Drobetsky, E. A., Turcotte, J. & Chateauneuf, A. A role for ultraviolet A in solar mutagenesis. Proc. Natl Acad. Sci. USA 92, 2350\u20132354 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5063_CR28","doi-asserted-by":"publisher","first-page":"13765","DOI":"10.1073\/pnas.0604213103","volume":"103","author":"S Mouret","year":"2006","unstructured":"Mouret, S. et al. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc. Natl Acad. Sci. USA 103, 13765\u201313770 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5063_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature14347","volume":"520","author":"G Gundem","year":"2015","unstructured":"Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353\u2013357 (2015).","journal-title":"Nature"},{"key":"5063_CR30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994\u20131007 (2012).","journal-title":"Cell"},{"key":"5063_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nmeth.2883","volume":"11","author":"A Roth","year":"2014","unstructured":"Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396\u2013398 (2014).","journal-title":"Nat. Methods"},{"key":"5063_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"5063_CR33","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research, N.","year":"2008","unstructured":"Cancer Genome Atlas Research, N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008).","journal-title":"Nature"},{"key":"5063_CR34","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-06-0127","volume":"66","author":"C Hunter","year":"2006","unstructured":"Hunter, C. et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res. 66, 3987\u20133991 (2006).","journal-title":"Cancer Res."},{"key":"5063_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12605","volume":"7","author":"S Behjati","year":"2016","unstructured":"Behjati, S. et al. Mutational signatures of ionizing radiation in second malignancies. Nat. Commun. 7, 12605 (2016).","journal-title":"Nat. Commun."},{"key":"5063_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1158\/2159-8290.CD-11-0028","volume":"1","author":"S Durinck","year":"2011","unstructured":"Durinck, S. et al. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 1, 137\u2013143 (2011).","journal-title":"Cancer Discov."},{"key":"5063_CR37","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1093\/bioinformatics\/btt546","volume":"29","author":"E Purdom","year":"2013","unstructured":"Purdom, E. et al. Methods and challenges in timing chromosomal abnormalities within cancer samples. Bioinformatics 29, 3113\u20133120 (2013).","journal-title":"Bioinformatics"},{"key":"5063_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"5063_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1054","volume":"33","author":"PM Pollock","year":"2003","unstructured":"Pollock, P. M. et al. High frequency of BRAF mutations in nevi. Nat. Genet. 33, 19\u201320 (2003).","journal-title":"Nat. Genet."},{"key":"5063_CR40","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/jnci\/djg123","volume":"95","author":"JL Maldonado","year":"2003","unstructured":"Maldonado, J. L. et al. Determinants of BRAF mutations in primary melanomas. J. Natl Cancer Inst. 95, 1878\u20131890 (2003).","journal-title":"J. Natl Cancer Inst."},{"key":"5063_CR41","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1158\/1541-7786.MCR-08-0532","volume":"7","author":"B Modrek","year":"2009","unstructured":"Modrek, B. et al. Oncogenic activating mutations are associated with local copy gain. Mol. Cancer Res. 7, 1244\u20131252 (2009).","journal-title":"Mol. Cancer Res."},{"key":"5063_CR42","doi-asserted-by":"publisher","first-page":"e111153","DOI":"10.1371\/journal.pone.0111153","volume":"9","author":"L Ding","year":"2014","unstructured":"Ding, L. et al. Clonal architectures and driver mutations in metastatic melanomas. PLoS ONE 9, e111153 (2014).","journal-title":"PLoS ONE"},{"key":"5063_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/path.4318","volume":"233","author":"K Harbst","year":"2014","unstructured":"Harbst, K. et al. Molecular and genetic diversity in the metastatic process of melanoma. J. Pathol. 233, 39\u201350 (2014).","journal-title":"J. Pathol."},{"key":"5063_CR44","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1158\/0008-5472.CAN-15-3476","volume":"76","author":"K Harbst","year":"2016","unstructured":"Harbst, K. et al. Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma. Cancer Res. 76, 4765\u20134774 (2016).","journal-title":"Cancer Res."},{"key":"5063_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","volume":"32","author":"LR Yates","year":"2017","unstructured":"Yates, L. R. et al. Genomic evolution of breast cancer metastasis and relapse. Cancer Cell 32, 169 (2017).","journal-title":"Cancer Cell"},{"key":"5063_CR46","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jso.20079","volume":"86","author":"U Leiter","year":"2004","unstructured":"Leiter, U., Meier, F., Schittek, B. & Garbe, C. The natural course of cutaneous melanoma. J. Surg. Oncol. 86, 172\u2013178 (2004).","journal-title":"J. Surg. Oncol."},{"key":"5063_CR47","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/1097-0142(19850315)55:6<1398::AID-CNCR2820550639>3.0.CO;2-A","volume":"55","author":"MM Urist","year":"1985","unstructured":"Urist, M. M. et al. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 55, 1398\u20131402 (1985).","journal-title":"Cancer"},{"key":"5063_CR48","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274\u2013284 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"5063_CR49","unstructured":"Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med.\u00a0\n                           376, 2109\u20132121 (2017)."},{"key":"5063_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1727","volume":"3","author":"H Shi","year":"2012","unstructured":"Shi, H. et al. Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance. Nat. Commun. 3, 724 (2012).","journal-title":"Nat. Commun."},{"key":"5063_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16967","volume":"531","author":"EM Kerr","year":"2016","unstructured":"Kerr, E. M., Gaude, E., Turrell, F. K., Frezza, C. & Martins, C. P. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities. Nature 531, 110\u2013113 (2016).","journal-title":"Nature"},{"key":"5063_CR52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1239947","volume":"343","author":"BE Johnson","year":"2014","unstructured":"Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189\u2013193 (2014).","journal-title":"Science"},{"key":"5063_CR53","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S2352-3026(15)00094-0","volume":"2","author":"K Leuraud","year":"2015","unstructured":"Leuraud, K. et al. Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study. Lancet Haematol. 2, e276\u2013e281 (2015).","journal-title":"Lancet Haematol."},{"key":"5063_CR54","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"5063_CR55","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"5063_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"5063_CR57","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811\u20131817 (2012).","journal-title":"Bioinformatics"},{"key":"5063_CR58","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes, S. A. et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805\u2013D811 (2015).","journal-title":"Nucleic Acids Res."},{"key":"5063_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1705-x","volume":"18","author":"F Zare","year":"2017","unstructured":"Zare, F., Dow, M., Monteleone, N., Hosny, A. & Nabavi, S. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data. BMC Bioinform. 18, 286 (2017).","journal-title":"BMC Bioinform."},{"key":"5063_CR60","unstructured":"R Core Team. (R Foundation for Statistical Computing, Vienna, Austria, 2016)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05063-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05063-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05063-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T15:21:14Z","timestamp":1671549674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05063-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["5063"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-05063-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,10]]},"assertion":[{"value":"11 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2665"}}